logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Theodoros Foukakis

karolinska institutet
H指数:42
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Glucocorticoid prophylaxis influences the systemic immune macroenvironment in patients with early stage, treatment naïve, HER2+ breast cancer

糖皮质激素预防对早期、治疗初治、HER2阳性乳腺癌患者的全身免疫宏观环境的影响

Immunotherapy Advances
IF4.9
2026-08-250
OA
Aine O’Reilly; Ioannis Zerdes; Max Backman; Yago Pico de Coana; Ulrika Edbäck; Emmanouil Sifakis; Stina Wickström; Kang Wang; Andreas Lundqvist; John MacSharry; Jonas Bergh; Thomas Hatschek; Theodoros Foukakis; Jana de Boniface; Rolf Kiessling
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study
Nature Communications
IF15.7
2026-06-240
OAAI
Davide Massa; Theodoros Foukakis; Sylvie Giacchetti; Christine Desmedt; Jean-Sebastien Frenel; Elisa Gasparini; Marleen Kok; Paolo Vigneri; William Jacot; Claudio Vernieri; Matteo Lambertini; Francesca Patanè; Federico Piacentini; Emilio Bria; Alberto Zambelli; Dario Trapani; Andrea Botticelli; Ornella Garrone; Stefania Lando; Alexios Matikas; Laetitia Someil; Giuseppe Floris; Mario Campone; Moira Ragazzi; Esther Lips; Federica Martorana; Giorgio Bonomi; Andri Papakonstantinou; Lorenzo Nicolè; Ioannis Zerdes; Patrick Neven; Martina Rotolo; Hugo Horlings; Sabrina Nucera; Amélie Gudin-De-Vallerin; Andrea Vingiani; Angelo Paolo Dei Tos; Valentina Guarneri; Maria Vittoria Dieci
Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: a systematic literature review of real-world evidence

曲拉曲坦在HER2阳性晚期/转移性乳腺癌患者中的应用：一项真实世界证据的系统文献综述

The Breast
IF0
2026-06-090
OAAI
Rodrigo Sanchez-Bayona; Carey Anders; Rupert Bartsch; David A. Cameron; Eva M. Ciruelos; Carmen Criscitiello; Francois P. Duhoux; Theodoros Foukakis; Jean-Sebastien Frenel; Joseph Gligorov; Peter A. Kaufman; Matteo Lambertini; Nathalie LeVasseur; Alicia Okines; Frédérique Penault-Llorca; Volkmar Müller; Matthew T. Blahna; Edward Neuberger; Sofia Simon; Emanuele Zanucco
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

新辅助palbociclib联合内分泌治疗与化疗在ER+/HER2-乳腺癌中的比较：一项随机II期试验

Nature Communications
IF15.7
2026-04-080
OAAI
Alexios Matikas; Evangelos Tzoras; Michail Sarafidis; Emmanouil G. Sifakis; Judith Bjöhle; Elin Barnekow; Sara Margolin; Erika Isaksson-Friman; Luisa Edman Kessler; Athanasios Zouzos; Hemming Johansson; Mats Hellström; Susanne Agartz; Per Grybäck; Dimitrios Salgkamis; Ioannis Zerdes; Kang Wang; Johan Hartman; Balazs Acs; Wenwen Sun; Ceren Boyaci; Guillermo Villacampa; Tomas Pascual; Joaquin Gavila; Aleix Prat; Charles Perou; Yvonne Brandberg; Jonas Bergh; Thomas Hatschek; Theodoros Foukakis
Integrating liquid biopsies and artificial intelligence for early cancer detection: A systematic review and meta-analysis

整合液体活检和人工智能用于早期癌症检测：一项系统评价和荟萃分析

European Journal of Cancer
IF7.1
2026-03-240
OAAI
Panagiotis Filis; Georgios Markozannes; Dimitrios Salgkamis; Nikos Tsiknakis; Ioannis Zerdes; Eirini Pagkalidou; Maria Manou; Nikolaos Filis; Andri Papakonstantinou; Dimitrios Mavroudis; Alexios Matikas; Konstantinos K. Tsilidis; Theodoros Foukakis
Pathological response to pembrolizumab-based neoadjuvant therapy in ER-low vs. ER-zero breast cancer: a Swedish population-based cohort study

帕博利珠单抗为基础的新辅助治疗在ER低表达与ER零表达乳腺癌中的病理学反应：一项瑞典基于人群的队列研究

Breast Cancer Research
IF5.6
2025-11-290
OAAI
Sanna Steen; Emelie Karlsson; Ida Björnheden; Gunilla Rask; Viktoria Thurfjell; Hampus Nobin; Blanka Kolodziej; Anna Bodén; Annette Bauer; Rickard Einefors; Per Nilsson; Ioannis Zerdes; Andri Papakonstantinou; Theodoros Foukakis; Irma Fredriksson; Mattias Rantalainen; Eugenia Colón-Cervantes; Anikó Kovács; Balazs Acs; Johan Hartman
Palbociclib with adjuvant endocrine therapy in early breast cancer: five-year follow up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)

帕博西利联合辅助内分泌疗法在早期乳腺癌中的应用：全球多中心、开放标签、随机III期PALLAS试验（ABCSG-42/AFT-05/PrE0109/BIG-14-13）五年随访分析

Annals of Oncology
IF65.4
2025-10-170
OAAI
E.L. Mayer; D. Hlauschek; M. Gnant; P.J. O'Brien; M. Bellet-Ezquerra; M.P. Goetz; M. Ruiz-Borrego; A. Chan; K. Clifton; D. Egle; D. Lake; P. Cabrera; T. Mamounas; G. Pristauz-Telsnigg; Z. Dayao; M. Gil Gil; D. Cameron; T. Traina; P.G. Morris; D. Sabanathan; G. Rinnerthaler; J. Meisel; A. Prat; A.C. Wolff; L-M. Tseng; C. Isaacs; C.F. Singer; G. Rubovszky; T. Foukakis; J. Jassem; E.P. Winer; M. Vetter; J. Federmann; O. Metzger; C. Schurmans; E. Gauthier; D.R. Lu; C. Fesl; A. Dueck; A. DeMichele
Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based study

乳腺癌患者接受阿贝西利或瑞博西利辅助治疗的患病率与预后：一项全国性基于人群的研究

The Lancet Regional Health - Europe
IF0
2025-09-290
OAAI
Xingrong Liu; Behnaz Binicy; Balazs Acs; Louise Eriksson Bergman; Sibylle Loibl; Michael Gnant; Michael Untch; Antonios Valachis; Jonas Bergh; Johan Hartman; Theodoros Foukakis; Alexios Matikas
Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort study

乳腺癌患者新辅助治疗期间肿瘤Ki-67动态变化的预后意义：一项基于人群的队列研究

lancet regional health europe
IF0
2025-09-020
PREAI
Maria Angeliki Toli; Xingrong Liu; Davide Massa; Stefania Lando; Caroline Boman; Nikolaos Tsiknakis; Christian Tranchell; Andri Papakonstantinou; Giuseppe Fotia; Claudio Vernieri; Valentina Guarneri; Jonas Bergh; Maria Vittoria Dieci; Louise Eriksson Bergman; Alexios Matikas; Theodoros Foukakis

研究方向

暂未获取到该数据
J
Jonas Bergh
H 指数:103论文数:942被引数:7.0万
A
Alexios Matikas
H 指数:24论文数:211被引数:2,269
I
Ioannis Zerdes
H 指数:18论文数:128被引数:1,387
E
Emmanouil G. Sifakis
H 指数:12论文数:70被引数:857
J
Johan Hartman
H 指数:47论文数:420被引数:1.1万
T
Thomas Hatschek
H 指数:37论文数:211被引数:6,663
K
Kang Wang
H 指数:31论文数:191被引数:2,942
H
Hemming Johansson
H 指数:52论文数:255被引数:1.0万
C
Catharina Larsson
H 指数:76论文数:468被引数:2.2万
M
Mats Hellström
H 指数:16论文数:79被引数:744